Original Research
Accepted on 17 Mar 2025
UPLC-Q-TOF-MS-Based Unbiased Serum Metabolomics Investigation of Cholangiocarcinoma
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1549223
Type at least 3 characters
5,367 articles
Review
Accepted on 17 Mar 2025
Use of AI-Methods over MD Simulations in the Sampling of Conformational Ensembles in IDPs
in Biological Modeling and Simulation
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1542267
- 194 views
Original Research
Published on 17 Mar 2025
Serum metabolic profiling of patients with diabetic kidney disease based on gas chromatography-mass spectrometry
in Metabolomics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1541440
- 366 views
Review
Published on 17 Mar 2025
Exploring chemical space for “druglike” small molecules in the age of AI
in Biological Modeling and Simulation
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1553667
- 522 views
Original Research
Accepted on 13 Mar 2025
TNFAIP8L3 regulation of TGF-β signaling pathway affects the proportion of macrophages during tumor antigen presentation and affects the prognosis of ovarian cancer
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1566363
Editorial
Published on 13 Mar 2025
Editorial: Metabolomics perspectives for clinical medicine, volume II
in Metabolomics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1577050
- 439 views
Original Research
Published on 13 Mar 2025
A dual-reporter LDLR system integrating fluorescence and luminescence for understanding LDLR regulation and facilitating drug discovery
in Lipids, Membranes and Membranous Organelles
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1552085
- 318 views
Original Research
Published on 13 Mar 2025
Investigation of sphingolipid-related genes in lung adenocarcinoma
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1548655
- 211 views
Original Research
Published on 13 Mar 2025
Network pharmacology combined with untargeted metabolomics reveals the intervention mechanism and compatibility of chenpi-rougui herb pair in nonalcoholic fatty liver disease
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1553162
- 419 views
Original Research
Accepted on 12 Mar 2025
Untargeted Metabolomics for Acute Intra-Abdominal Infection Diagnosis in Serum and Urine using UHPLC-TripleTOF MS
in Metabolomics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1534102
Original Research
Published on 12 Mar 2025
Expression and distribution of activin-follistatin-inhibin axis in the urinary bladder
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1519977
- 500 views
Editorial
Published on 12 Mar 2025
Editorial: Molecular basis of the energy management in cells: implications in health and disease
in Lipids, Membranes and Membranous Organelles
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1578972
- 408 views
Original Research
Published on 12 Mar 2025
Integrative multi-omics analysis and machine learning refine global histone modification features in prostate cancer
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1557843
- 860 views
Opinion
Accepted on 10 Mar 2025
CHALLENGES IN MYELOPEROXIDASE QUANTIFICATION: THE INADEQUACIES OF CURRENT COLORIMETRIC APPROACHES
in Cellular Biochemistry
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1559499
Original Research
Published on 10 Mar 2025
Computational electrostatic engineering of nanobodies for enhanced SARS−CoV−2 receptor binding domain recognition
in Structural Biology
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1512788
- 730 views
Original Research
Accepted on 07 Mar 2025
Metabolic readouts of tumor instructed normal tissues (TINT) identify aggressive prostate cancer subgroups for tailored therapy The metabolome of benign prostate tissues is influenced by nearby tumors of high grade
in Metabolomics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1426949